SPINAL STABILIZATION TECHNOLOGIES LIMITED

Spinal Stabilisation Technologies Limited is an international medical‑device company dedicated to advancing treatment for chronic low‑back pain caused by degenerative disc disease. Their flagship innovation, the PerQdisc™ Nucleus Replacement System, is a less‑invasive, silicone‑based prosthesis that replaces the diseased nucleus pulposus in situ, aiming to restore physiological motion and redistribute load across the lumbar disc.

The patented PerQdisc™ offers a motion‑preserving surgical option for patients suffering from discogenic lumbar low‑back pain, providing an alternative to more invasive fusion procedures. By emulating the natural function of the native nucleus, the system seeks to alleviate pain while maintaining the spine’s natural biomechanics.

Spinal Stabilisation Technologies focuses on research‑driven solutions, currently conducting the DISCPAIN1 clinical trial to evaluate the safety and efficacy of its technology. While the device remains investigational and is not yet approved for commercial sale in the United States or CE‑marked regions, the company continues to pioneer innovative approaches for those living with chronic disc‑related discomfort.